Eckhardt Sue Gail
Insider CIK 1823769 · SYRS Director · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EXEL EXELIXIS, INC. | S Sale | 2026-06-01 | 2026-06-03 | 9,812 | $50.14 | $492.0K | 16,079 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2026-05-27 | 2026-05-29 | 8,367 | — | $0 | 25,891 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-02-13 | 2026-02-18 | 3,856 | $43.79 | $168.9K | 17,524 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-06-02 | 2025-06-04 | 4 | $43.67 | $175 | 21,380 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-06-02 | 2025-06-04 | 18,834 | $42.74 | $805.0K | 21,384 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2025-05-29 | 2025-05-30 | 9,812 | — | $0 | 40,218 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2025-02-14 | 2025-02-19 | 7,712 | — | $0 | 23,136 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-02-14 | 2025-02-19 | 7,712 | $35.01 | $270.0K | 34,262 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2025-02-14 | 2025-02-19 | 7,712 | $23.24 | $179.2K | 41,974 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-02-14 | 2025-02-19 | 3,856 | $35.04 | $135.1K | 30,406 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2024-05-31 | 2024-06-04 | 18,838 | — | $0 | 34,262 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2024-01-05 | 2024-01-09 | 30,848 | — | $0 | 30,848 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2024-01-05 | 2024-01-09 | 15,424 | — | $0 | 15,424 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-09-08 | 2020-09-09 | 35,000 | — | $0 | 35,000 | SEC↗ |